New money for chronic diseases: can clinicians and entrepreneurs deliver outcomes eluding governments?

Med J Aust

Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Published: September 2012

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja12.10047DOI Listing

Publication Analysis

Top Keywords

money chronic
4
chronic diseases
4
diseases clinicians
4
clinicians entrepreneurs
4
entrepreneurs deliver
4
deliver outcomes
4
outcomes eluding
4
eluding governments?
4
money
1
diseases
1

Similar Publications

In 2022, a community-academic collaborative team published 5 key recommendations for developing a national action plan to advance the sexual and reproductive health and rights (SRHR) of women living with HIV in Canada. In 2023, a national gathering was convened to strategize implementation of the recommendations across policy, practice, and research settings. Discussions highlighted that meaningful engagement of women living with HIV (recommendation 1) is foundational to implementing the other recommendations.

View Article and Find Full Text PDF
Article Synopsis
  • A significant number of patients experience chronic pain after surgery, highlighting the urgent need for predictive models that consider bio-psycho-social and physiological factors.
  • A study involving male volunteers assessed pain characteristics, psychological factors, and blood proteomics before and after an experimental incision to predict outcomes related to pain intensity and hyperalgesia.
  • The results revealed that a combination of diverse parameters could predict pain responses more accurately than single features, identified specific protein signatures associated with inflammation, and suggested repurposing existing medications for better pain management.
View Article and Find Full Text PDF

Structured medication reviews (SMRs) were introduced into the National Health Service (NHS) Primary Care to support the delivery of the NHS Long-Term Plan for medicines optimization. SMRs improve the quality of care, reduce harm and offer value for money. However, evidence to support SMRs for patients with chronic kidney disease (CKD) stage G4-5D with elevated risk of cardiovascular disease and premature mortality is unknown.

View Article and Find Full Text PDF

Deep proteomics and network pharmacology reveal sex- and age-shared neuropathic pain signatures in mouse dorsal root ganglia.

Pharmacol Res

January 2025

Division of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria. Electronic address:

Our understanding of how sex and age influence chronic pain at the molecular level is still limited with wide-reaching consequences for adolescent patients. Here, we leveraged deep proteome profiling of mouse dorsal root ganglia (DRG) from adolescent (4-week-old) and adult (12-week-old) male and female mice to investigate the establishment of neuropathic pain in the spared nerve injury (SNI)-model in parallel. We quantified over 12,000 proteins, including notable ion channels involved in pain, highlighting the sensitivity of our approach.

View Article and Find Full Text PDF

Sodium-glucose cotransporter 2 inhibitors for chronic kidney disease: Why, when and when not.

Aust J Gen Pract

December 2024

FRCP, FRACP, Consultant Physician, Department of General Medicine and Acute Assessment Unit, Canberra Hospital, Canberra, ACT; Clinical Associate Professor, Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA; Associate Professor, ANU College of Health and Medicine, Australian National University, Canberra, ACT.

Background: Chronic kidney disease (CKD) is a significant healthcare problem. More advanced stages are associated with increased mortality, morbidity and cost. Instigating measures to slow down disease progression at an early stage can save lives, and millions of dollars of taxpayers' money.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!